Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance.

Wells L, Vosseller K, Hart GW.

Cell Mol Life Sci. 2003 Feb;60(2):222-8. Review.

PMID:
12678487
3.

Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.

Chatham JC, Nöt LG, Fülöp N, Marchase RB.

Shock. 2008 Apr;29(4):431-40. Review.

PMID:
17909453
4.

O-GlcNAc modification of nucleocytoplasmic proteins and diabetes.

Akimoto Y, Hart GW, Hirano H, Kawakami H.

Med Mol Morphol. 2005 Jun;38(2):84-91. Review.

PMID:
15944815
5.

Glycan-dependent signaling: O-linked N-acetylglucosamine.

Hanover JA.

FASEB J. 2001 Sep;15(11):1865-76. Review.

PMID:
11532966
6.

[O-GlcNAc glycosylation and regulation of cell signaling].

Issad T.

Med Sci (Paris). 2010 Aug-Sep;26(8-9):753-9. doi: 10.1051/medsci/2010268-9753. Review. French.

7.

O-GlcNAc modification, insulin signaling and diabetic complications.

Issad T, Masson E, Pagesy P.

Diabetes Metab. 2010 Dec;36(6 Pt 1):423-35. doi: 10.1016/j.diabet.2010.09.001. Epub 2010 Nov 11. Review.

PMID:
21074472
8.

Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes.

Teo CF, Wollaston-Hayden EE, Wells L.

Mol Cell Endocrinol. 2010 Apr 29;318(1-2):44-53. doi: 10.1016/j.mce.2009.09.022. Epub 2009 Sep 30. Review.

9.

Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins.

Hart GW, Housley MP, Slawson C.

Nature. 2007 Apr 26;446(7139):1017-22. Review.

PMID:
17460662
10.

Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc.

Wells L, Vosseller K, Hart GW.

Science. 2001 Mar 23;291(5512):2376-8. Review.

PMID:
11269319
11.

The hexosamine signaling pathway: deciphering the "O-GlcNAc code".

Love DC, Hanover JA.

Sci STKE. 2005 Nov 29;2005(312):re13. Review.

PMID:
16317114
12.

Hexosamines, insulin resistance, and the complications of diabetes: current status.

Buse MG.

Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E1-E8. Review.

13.

O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks.

Slawson C, Housley MP, Hart GW.

J Cell Biochem. 2006 Jan 1;97(1):71-83. Review.

PMID:
16237703
14.

O-GlcNAcylation, an original modulator of contractile activity in striated muscle.

Cieniewski-Bernard C, Montel V, Stevens L, Bastide B.

J Muscle Res Cell Motil. 2009 Dec;30(7-8):281-7. doi: 10.1007/s10974-010-9201-1. Epub 2010 Feb 25. Review.

PMID:
20182775
15.

The role of O-linked protein glycosylation in beta-cell dysfunction.

Konrad RJ, Kudlow JE.

Int J Mol Med. 2002 Nov;10(5):535-9. Review.

PMID:
12373287
16.
17.

The brown adipose cell: a unique model for understanding the molecular mechanism of insulin resistance.

Valverde AM, Benito M.

Mini Rev Med Chem. 2005 Mar;5(3):269-78. Review.

PMID:
15777261
18.

[Role of O-GlcNAc modification of cellular proteins in signal transduction].

Krześlak A.

Postepy Biochem. 2007;53(4):389-99. Review. Polish.

PMID:
19024903
19.

Nutrient-induced insulin resistance in human skeletal muscle.

Krebs M, Roden M.

Curr Med Chem. 2004 Apr;11(7):901-8. Review.

PMID:
15078172
20.

Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.

Copeland RJ, Bullen JW, Hart GW.

Am J Physiol Endocrinol Metab. 2008 Jul;295(1):E17-28. doi: 10.1152/ajpendo.90281.2008. Epub 2008 Apr 29. Review.

Supplemental Content

Support Center